Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Ascites Hepatic: early-phase trial registry

3 of 3 indexed Ascites Hepatic trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Ascites Hepatic: 3 US clinical trials tracked, 3 recruiting.

Ascites Hepatic is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Anahita Rabiee MD MHS, running 1 of these trials.

Enrollment posture brief

Registry condition ascites-hepatic

OPEN 3 | RECR 100% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Ascites Hepatic (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Ascites Hepatic

Ascites Hepatic lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ascites Hepatic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ascites Hepatic is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Ascites Hepatic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Albumin infusion (25% albumin) Drug
1 trials
Quality of Life surveys Diagnostic test
1 trials
Normal Saline (0.9% NaCl) Drug
1 trials
PHIN-214 Subcutaneous injection Drug
1 trials

US sites by state

Facility locations filed on Ascites Hepatic trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Texas 1 trials
Ohio 1 trials
Minnesota 1 trials
Louisiana 1 trials
Connecticut 1 trials
California 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ascites Hepatic page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ascites Hepatic condition card totals 3 registered trials; most-linked intervention Albumin infusion (25% albumin); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.